without the 3 million in revenue from the repurchased hsic units in 2012, biol lost more in 2012, than it did in 2012. so neg 6.1 million in 2012 without the hsic buyback units? but sales are sales right? as long as biol gets bailed out by another overstuffed distributor in 2013. great turn around...
since you want to quote the 10:
"We have experienced net losses for each of the past three years and we may experience additional losses and have difficulty achieving profitability in the future.
We have an accumulated deficit of approximately $112.3 million at December 31, 2012. We recorded net losses of approximately $3.1 million, $4.5 million, and $12.0 million for the years ended December 31, 2012, 2011, and 2010, respectively. In order to achieve profitability, we must control our costs and increase net revenue through new sales. Failure to increase our net revenue and decrease our costs could cause our stock price to decline."
I think that Biolase has a great product, maybe the best in the industry. Doing a quick google search of people working for Biolase shows that the people working there really believe its a great product. The common problem that their staff complain of has been poor management. This may be contributing to the past low sales.
Now, they are looking at seIling directly to the customer, and I think that they are heading in the right direction with that.